Magnesium Sulfate Heptahydrate Ibe

Magnesium sulfate heptahydrate, the active ingredient in Magnesium Sulfate Heptahydrate Ibe, is a magnesium salt presented as a sterile injectable solution for intramuscular and intravenous use. It is employed to prevent and treat eclampsia, correct magnesium deficiency, and manage certain cardiac arrhythmias.

GNH USA supplies Magnesium Sulfate Heptahydrate Ibe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnesium sulfate heptahydrate acts on electrolyte balance and neuromuscular transmission, making it useful in several acute clinical settings. - Eclampsia and severe pre‑eclampsia: prevents seizures and stabilises maternal blood pressure during pregnancy. - Magnesium deficiency: restores normal serum magnesium levels in patients with low magnesium. - Ventricular arrhythmias (e.g., torsades de pointes): reduces the duration and frequency of life‑threatening heart rhythm disturbances. - Severe asthma exacerbations: provides adjunct bronchodilation and reduces airway hyper‑responsiveness.

Adverse reactions may vary with dose, infusion rate, and patient comorbidities.

Common Side Effects: - Flushing or feeling of warmth - Sweating - Nausea or vomiting - Headache - Mild hypotension - Dizziness

Serious or Rare Side Effects: - Severe hypotension or cardiovascular collapse - Respiratory depression or apnea - Cardiac arrest - Hypermagnesemia with neuromuscular weakness - Allergic reactions including anaphylaxis - Prolonged neuromuscular blockade

Magnesium sulfate should be used with careful clinical monitoring and appropriate laboratory testing. - Renal impairment: avoid or adjust dose, as reduced clearance can lead to accumulation. - Neuromuscular disease (e.g., myasthenia gravis): monitor for exaggerated muscle weakness. - Cardiac disease: observe blood pressure and heart rhythm continuously. - Pregnancy: reserve for situations where maternal benefit outweighs fetal risk. - Concomitant medications: review for agents that affect magnesium levels or neuromuscular transmission. - Store at ambient temperature: keep in original container, protect from moisture and direct light.

Magnesium sulfate can alter the effects of several drug classes, requiring vigilance.

Major Interactions (Avoid): - Calcium channel blockers: additive hypotensive effect may be dangerous. - Neuromuscular blocking agents: prolonged paralysis and respiratory compromise. - Other magnesium‑containing products: risk of hypermagnesemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance blood pressure lowering. - Loop diuretics: can affect renal magnesium handling and serum levels. - Aminoglycoside antibiotics: increased risk of neuromuscular toxicity.